Analysis Sensus Healthcare Inc (SRTS)
5/29/2024
Analysis of Sensus Healthcare Inc (SRTS)
Sensus Healthcare Inc (SRTS) has shown some interesting price movements recently. The stock closed at $5.41 on May 28th, after opening at $6.17. This indicates a downward trend in the short term.The Relative Strength Index (RSI) is at 56.83, suggesting that the stock is neither overbought nor oversold. The Moving Average Convergence Divergence (MACD) indicator is positive at 0.60, with the MACD line above the signal line, indicating a bullish signal.
Looking at the moving averages, the Simple Moving Average (SMA) is at 4.67, the Exponential Moving Average (EMA) is at 4.84, and the Weighted Moving Average (WMA) is at 5.03. These values suggest a downward trend in the stock price.
Overall, based on the RSI, MACD, and moving averages, Sensus Healthcare Inc may be experiencing a short-term downward trend, but the bullish MACD signal could indicate a potential reversal in the near future. It would be advisable to monitor the stock closely for any signs of a trend reversal.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and operating margin. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The company has a good return on assets and return on equity.
The stock statistics indicate a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, including its beta, moving averages, and the range of its 52-week high and low.
Valuation metrics suggest that the stock may be overvalued based on its PEG ratio, forward and trailing P/E ratios, and price to book and price to sales ratios. The company's market capitalization and enterprise value are also provided.
Lastly, the dividends and splits information includes details about the company's dividend payments, dividend yield, payout ratio, and historical stock splits.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in revenue from FY 2020 to FY 2022.
- The revenue in FY 2023 is still higher than that in FY 2021 and FY 2020.
These trends indicate fluctuations in the company's revenue over the years, with a notable decrease in the most recent fiscal year.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with cash and cash equivalents showing fluctuations.
3. Non-current assets consist mainly of investments and advances, which have been increasing steadily.
4. Total liabilities have also been increasing, with a significant portion being long-term debt.
5. Shareholders' equity has shown variations but has generally been positive, indicating a healthy financial position.
6. The company has been investing in machinery, furniture, and equipment, as seen in the non-current assets section.
7. The company has been managing its short-term and long-term debts over the years.
8. The provision for risks and charges has been relatively stable compared to other financial elements.
9. The company has been retaining earnings, which have contributed to the shareholders' equity.
10. Overall, the financial health of the company seems stable, with a focus on investments and managing debts.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Number of Analysts: 26
- Year Ago EPS: $1.26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Number of Analysts: 25
- Year Ago EPS: $1.46
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Number of Analysts: 39
- Year Ago EPS: $6.13
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Number of Analysts: 39
- Year Ago EPS: $6.59
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next fiscal year. The average estimates are showing growth compared to the previous year's EPS figures, indicating optimism among analysts regarding the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a significant sales growth of 6% compared to the current fiscal year.
Overall, the analysts are forecasting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, indicating positive performance and potential expansion for the company.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be positive.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median estimate of $200. However, there is a wide range of estimates, from a low of $164 to a high of $250. The current price of $191.57 is below both the average and median forecast, suggesting that there may be potential for growth according to the analysts' predictions.
MACD of SRTS
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
